YARW insider filings

Yarrow Bioscience, Inc. — 8 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-10-30. Screen YARW transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 5 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
Alford Rachael — Chief Operating Officer1——1
Frey Rebecca — Chief Executive Officer, Director1——1
Payton Lori — Chief Development Officer1——1
Ryder Steven — Chief Medical Officer1——1
Zeronda Tyler — Chief Financial Officer1——1

Recent insider filings — Yarrow Bioscience, Inc.

FiledFormInsiderReported transactionsSource
2026-10-304Payton Lori — Chief Development OfficerGrant/award (A): 99,827 (derivative) @ $0EDGAR
2026-10-304Ryder Steven — Chief Medical OfficerGrant/award (A): 113,137 (derivative) @ $0EDGAR
2026-10-304Frey Rebecca — Chief Executive Officer, DirectorGrant/award (A): 465,857 (derivative) @ $0EDGAR
2026-10-304Alford Rachael — Chief Operating OfficerGrant/award (A): 89,844 (derivative) @ $0EDGAR
2026-10-304Zeronda Tyler — Chief Financial OfficerGrant/award (A): 156,115 (derivative) @ $0EDGAR
2026-07-304RTW Fund Group GP, LLC — 10% owner
WONG RODERICK — 10% owner
Other (J): 133,290 @ $0 · Other (J): 133,290 (derivative) @ $0EDGAR
2026-07-294Ashiya Mona — DirectorGrant/award (A): 15,435 (derivative) @ $0EDGAR
2026-07-294Zeronda Tyler — DirectorGrant/award (A): 185,798 (derivative) @ $0EDGAR

Recent 8-K events — Yarrow Bioscience, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-128-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-148-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-108-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-138-K/A2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-308-K8.01 — Other EventsEDGAR
2026-07-288-K1.01 — Entry into a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
2.02 — Results of Operations and Financial Condition
3.02 — Unregistered Sales of Equity Securities
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.05 — Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-218-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-208-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-07-148-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-108-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=YARW returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs